1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. BAXTER INTERNATIONAL INC.
Baxter International Inc.
XNYS: BAX
25.28-0.48(-1.86%)
4.4M
XNYS Volume

XNYS 16 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Baxter International quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Baxter International share price target, revenues, EPS, net income and more

Baxter International quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Baxter International Jun-2026 Quarterly Revenue is $2,960 Million which is growth of 5.3% YoY.

  • POSITIVE

    Quarterly Net Profit Baxter International Jun-2026 Quarterly Net Profit is $126 Million which is growth of 38.5% YoY.

Baxter International Inc., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
2,9602,7012,9742,8352,8102,6252,7532,6993,8123,5923,8853,7083,707
Cost Of Rev.
1,9281,8102,3971,8851,8191,7641,7941,6662,3812,2052,4132,5912,596
Gross Profit
1,0328915779509918619591,0331,4311,3871,4721,1171,111
⌄
8158258217788008039608831,1941,2031,1491,1681,129
Operating Profit
21766-24417219158-1150237184323-51-18
-64-66-58-58-58-64-90-87-85-78-73-128-124
Profit Before Tax
158-6-756121133-3-52169-257116238-172-183
Tax
231127917211-67-3385477165-22310
⌄
126-15-1,128-4691126-512140-314372452,508-141
Diluted NI Avail to Com Stockholders Ann.
126-15-1,128-4691126-512140-314372452,508-141
Basic EPS
0.2-0-2.2-0.10.20.3-10.3-0.60.10.55-0.3
Diluted EPS After ExtraOrdinary
0.60.40.40.70.60.60.60.50.70.70.90.70.7
Number Of Shares End
517515513514513512513510510508506507506
Net Income Continuing Discontinued Operations
126-15-1,128-4691126-512140-314372452,508-141
Normalized Income
29018818535330428529725234853.2449347335
Interest Income
131211101417101419254488
Interest
777869687281100101104103117136132
Net Interest Income
-64-66-58-58-58-64-90-87-85-78-73-128-124
EBIT
22260-69817919161-431156-172194311-44-59
EBITDA
461297-458416448308-186285116529635267250
Reconciled Cost Of Rev.
1,9281,8102,3971,8851,8191,7641,7941,6662,3812,2052,4132,5912,596
Reconciled Depr.
239237240237257247245129288335324311309
Profit From Continuing Operations
135-17-1,035-5112264-488434-311397351-238
Normalized EBITDA
47632122432472335262301564561697285313
*All financials are in USD Million and price data in USD

Baxter International competitor comparison and performance snapshot within industry

Baxter International annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue Baxter International Dec-2025 Annual Revenue is $11,244 Million which is growth of 5.7% YoY.

  • NEGATIVE

    Annual Net Profit Baxter International Dec-2025 Annual Net Profit is $-957 Million which is growth of -47.5% YoY.

Baxter International Inc., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-9.4%
-0.7%
 11,24410,63614,81315,11312,78411,67311,36211,12710,56110,1639,968
Cost Of Rev. Ann.
-6.8%
2.1%
8,0207,8656,6529,8389,7167,6797,0866,6016,3466,0996,0535,822
Gross Profit Ann.
-14.5%
-5.9%
3,4503,3793,9844,9755,3975,1054,5874,7614,7814,4624,1104,146
Operating Exp. Ann.
-10.7%
1.4%
3,2393,2023,5454,6054,4923,4012,9903,1303,1823,2043,3863,697
Operating Profit Ann.
-42%
-35.6%
2111774393709051,7041,5971,6311,5991,258724449
-
-
-246-238-341-442-395-192-134-71-45-55-66-126
Other Exp. Ann.
-
-
 -444-387-32-2,863-35-171-590139144,296105
PBT Ann.
-
-
-483-505-289-103-2,3531,4771,2929701,6931,2174,954428
Tax Ann.
79.8%
16.8%
48539537-3468182182-4163493-1235
⌄
-
-
-1,063-957-6492,656-2,4331,2841,1021,0011,6247174,965968
Diluted NI Avail to Com Stockholders Ann.
-
-
-1,063-957-6492,656-2,4331,2841,1021,0011,6247174,965968
EPS Ann.
-
-
 -1.9-1.35.3-4.82.62.2231.39.11.8
Diluted EPS Ann.
-
-
 -1.9-1.35.3-4.82.52.11.931.391.8
Number Of Shares End
0.4%
0.2%
 513513506507499509506528543543548
Total Exp. Ann.
-8%
1.9%
 11,06710,19714,44314,20811,08010,0769,7319,5289,3039,4399,519
Net Income Continuing Discontinued Operations Ann.
-
-
-1,063-957-6492,656-2,4331,2841,1021,0011,6247174,965968
Normalized Income Ann.
-13.8%
-2.7%
1,0161,1362611,3271,7721,8361,303.31,0191,666806.21,078755
Interest Income Ann.
37.5%
22.3%
465267702014194048302320
Interest Ann.
-11.3%
13.6%
292290408512415206153111938589146
EBITDA Ann.
-
-20.5%
7167141,0491,602-5552,5592,2491,8302,5232,0335,8201,313
Reconciled Cost Of Rev. Ann.
-6.8%
2.1%
8,0207,8656,6529,8389,7167,6797,0866,6016,3466,0996,0535,822
Reconciled Depr. Ann.
-11.2%
3.6%
9539819971,2631,403890823789785761800759
Profit From Continuing Operations Ann.
-
-
-968-900-326-69-2,4211,2951,1101,0111,6307244,966393
Normalized EBITDA Ann.
-18.9%
-12%
1,2511,2611,5631,7512,3672,5982,3951,7652,4922,0431,5781,260
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
5.7%
2Y CAGR
-12.9%
3Y CAGR
-9.4%
5Y CAGR
-0.7%
7Y CAGR
0.1%
10Y CAGR
1.2%
Total Revenue Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
-9.7%
2Y CAGR
-16.6%
3Y CAGR
-10.7%
5Y CAGR
1.4%
7Y CAGR
0.1%
10Y CAGR
-1.4%
Operating Expenses Annual Cr is falling faster than historical averages.

Baxter International balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund Baxter International Dec-2025 Total Shareholders Fund is $6,129 Million which is growth of -12.0% YoY.

  • NEGATIVE

    Total Assets Baxter International Dec-2025 Total Assets is $20,055 Million which is growth of -22.2% YoY.

Baxter International Inc., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-10.8%
0%
20,05525,78228,27628,28733,52120,01918,19315,64117,11115,54620,975
⌄
-14.6%
4.3%
13,95318,75819,80822,39224,40011,29310,2817,8257,9957,26612,110
⌄
1.7%
-6.7%
6,1296,9648,4025,8339,0778,6897,8827,7949,1248,2908,846
Total Capitalization Ann.
-9.5%
1.5%
15,60217,33819,53221,06526,22614,47512,69111,26712,63311,06912,781
Tangible Assets Ann.
-
-
-3,169-3,534-4,191-7,803-8,5513,8013,3813,4384,6514,5844,810
Working Capital Ann.
6.1%
-5.1%
3,9022,3423,0973,2664,6365,0784,2733,0834,4423,8306,046
Invested Capital Ann.
-11.4%
1%
15,60520,09022,20022,46926,73714,88113,23211,27112,63611,07215,366
Tangible Book Value Ann.
-
-
-3,169-3,534-4,191-7,803-8,5513,8013,3813,4384,6514,5844,810
Borrowings Ann.
-17.2%
7.5%
9,78013,44914,36417,21318,3106,8045,9613,4773,5122,7826,520
Net Debt Ann.
-20.4%
25%
7,51011,36210,60414,91814,7092,4622,0151,645118-4,307
Share Issued Ann.
0%
0%
683.5683.5683.5683.5683.5683.5683.5683.5683.5683.5683.5
Number Of Shares End
0.4%
0.2%
513513506507499509506528543543548
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
-22.2%
2Y CAGR
-15.8%
3Y CAGR
-10.8%
5Y CAGR
0%
7Y CAGR
3.6%
10Y CAGR
-0.4%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-54.4%
2Y CAGR
-32.4%
3Y CAGR
-14.5%
5Y CAGR
-2.3%
7Y CAGR
0.7%
10Y CAGR
-6.4%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-12%
2Y CAGR
-14.6%
3Y CAGR
1.7%
5Y CAGR
-6.7%
7Y CAGR
-3.4%
10Y CAGR
-3.6%
Total ShareHolders Funds Annual is falling faster than historical averages.

Baxter International ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share Baxter International Book Value Per Share is $12 which is growth of -12.5% YoY.

  • NEUTRAL

    ROE Baxter International ROE is 0% which is growth of 0% YoY.

Baxter International Inc., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--2.40%9.39%-7.87%4.80%5.77%5.92%9.92%4.39%27.19%4.13%
ROE Ann. %
-
-
--8.45%37.32%-32.64%14.45%13.30%12.77%19.20%8.23%57.95%11.41%
ROIC %
-
-
--2.11.31.21.41.3-0.13-0.52.31.6
OPM Ann. %
-36%
-35.1%
1.57%4.13%2.50%5.99%13.33%13.68%14.35%14.37%11.91%7.12%4.50%
Inventory Turnover Ratio Ann.
-
-
-2.73.63.83.5444.14.242.3
Asset Turnover Ann. %
-
-
-0.40.50.50.50.60.70.70.70.60.4
Working Capital Turnover Ann.
-14.3%
4.7%
2.94.54.84.62.82.32.73.62.42.71.7
Quick Ratio Ann.
-
-
-0.50.90.91.31.71.61.31.81.61.6
Current Ratio Ann.
-
-
-1.41.51.72.12.52.32.12.62.42.1
Interest Coverage Ratio Ann.
-
-
-0.30.8-4.78.29.49.719.215.356.73.9
LT Debt To Equity Ann.
-
-
-1.51.42.720.70.70.50.40.30.4
*All financials are in USD Million and price data in USD

Baxter International cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • POSITIVE

    Cash From Operating Activity Baxter International Dec-2025 Cash From Operating Activity is $951 Million which is growth of 16.1% YoY.

  • NEGATIVE

    Net Cash Flow Baxter International Dec-2025 Net Cash Flow is $-3,729 Million which is growth of -454.9% YoY.

Baxter International Inc., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-7.7%
-12.6%
9518191,7021,2112,2221,8702,1102,0961,8531,6241,129
-
-
-464-410-672-931-11,200-1,179-1,100-938-1,310-730-861
-
-
-4,216-1,081-3,489-1,4388,245-345498-2,60361-324-357
Cash Plus Cash Eqv. End Of Year Ann.
4.6%
-12%
1,9682,4143,1981,7222,9563,7363,3351,8323,3942,8012,213
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-530-6881,450-1,158-7333441,502-1,445588615-517
Cash Plus Cash Eqv. Begin Of Year Ann.
-6.5%
-6.3%
2,4143,1981,7222,9563,7363,3351,8383,3942,8012,2132,925
Income Tax Paid Supplemental Data Ann.
-
-
-223----294302255500466
Interest Paid Supplemental Data Ann.
-
-
303401----103948099178
Capex Ann.
-
-
-522-460-692-679-743-709-696-681-634-719-911
Issuance Of Capital Stock Ann.
-
-
-----------
Issuance Of Debt Ann.
-
1.2%
1,9982,12611,9031,8851,8836331,6416,868
Repayment Of Debt Ann.
-
-
-5,789-2,657-2,634-954-2,823-1,407--5-1-1,397-3,776
Repurchase Of Capital Stock Ann.
-
-
--32-600-500-1,270-2,452-564-292
Free Cash Flow Ann.
-6.9%
-18.1%
4293591,0105321,4791,1611,4141,4151,219905218
*All financials are in USD Million and price data in USD
Cash from Operating Act. Ann.
1Y CHG
16.1%
2Y CAGR
-25.3%
3Y CAGR
-7.7%
5Y CAGR
-12.6%
7Y CAGR
-10.7%
10Y CAGR
-1.7%
Cash from Operating Activity Annual growth is higher than historical averages.